Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

NASDAQ:SRAD - CH1134239669 - Common Stock

31.69 USD
-0.1 (-0.31%)
Last: 8/27/2025, 11:19:07 AM
Fundamental Rating

6

Taking everything into account, SRAD scores 6 out of 10 in our fundamental rating. SRAD was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. SRAD has an excellent financial health rating, but there are some minor concerns on its profitability. SRAD is valued quite expensively, but it does show have an excellent growth rating. These ratings would make SRAD suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year SRAD was profitable.
SRAD had a positive operating cash flow in the past year.
In the past 5 years SRAD has always been profitable.
SRAD had a positive operating cash flow in each of the past 5 years.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of SRAD (4.61%) is better than 65.65% of its industry peers.
SRAD's Return On Equity of 11.52% is fine compared to the rest of the industry. SRAD outperforms 68.70% of its industry peers.
The Return On Invested Capital of SRAD (4.66%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SRAD is significantly below the industry average of 15.87%.
The last Return On Invested Capital (4.66%) for SRAD is above the 3 year average (3.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.61%
ROE 11.52%
ROIC 4.66%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

With a decent Profit Margin value of 9.20%, SRAD is doing good in the industry, outperforming 71.76% of the companies in the same industry.
SRAD's Profit Margin has been stable in the last couple of years.
SRAD's Operating Margin of 10.53% is in line compared to the rest of the industry. SRAD outperforms 58.78% of its industry peers.
SRAD's Operating Margin has been stable in the last couple of years.
SRAD has a Gross Margin of 73.35%. This is amongst the best in the industry. SRAD outperforms 89.31% of its industry peers.
In the last couple of years the Gross Margin of SRAD has declined.
Industry RankSector Rank
OM 10.53%
PM (TTM) 9.2%
GM 73.35%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

SRAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SRAD has been increased compared to 1 year ago.
The number of shares outstanding for SRAD has been increased compared to 5 years ago.
SRAD has a better debt/assets ratio than last year.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 4.34 indicates that SRAD is not in any danger for bankruptcy at the moment.
SRAD has a Altman-Z score of 4.34. This is amongst the best in the industry. SRAD outperforms 83.21% of its industry peers.
SRAD has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
SRAD's Debt to FCF ratio of 0.35 is amongst the best of the industry. SRAD outperforms 93.13% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that SRAD is not too dependend on debt financing.
The Debt to Equity ratio of SRAD (0.04) is better than 83.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 4.34
ROIC/WACC0.83
WACC5.58%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.31 indicates that SRAD should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.31, SRAD is doing good in the industry, outperforming 66.41% of the companies in the same industry.
SRAD has a Quick Ratio of 1.31. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.31, SRAD is doing good in the industry, outperforming 68.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 230.77% over the past year.
The Earnings Per Share has been growing by 21.84% on average over the past years. This is a very strong growth
Looking at the last year, SRAD shows a quite strong growth in Revenue. The Revenue has grown by 19.38% in the last year.
SRAD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.81% yearly.
EPS 1Y (TTM)230.77%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%3306.25%
Revenue 1Y (TTM)19.38%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%14.14%

3.2 Future

The Earnings Per Share is expected to grow by 66.45% on average over the next years. This is a very strong growth
Based on estimates for the next years, SRAD will show a quite strong growth in Revenue. The Revenue will grow by 14.60% on average per year.
EPS Next Y282.53%
EPS Next 2Y106.68%
EPS Next 3Y80.58%
EPS Next 5Y66.45%
Revenue Next Year17.13%
Revenue Next 2Y17.03%
Revenue Next 3Y16.3%
Revenue Next 5Y14.6%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 63.38, which means the current valuation is very expensive for SRAD.
SRAD's Price/Earnings ratio is in line with the industry average.
SRAD's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.08.
Based on the Price/Forward Earnings ratio of 57.86, the valuation of SRAD can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRAD indicates a slightly more expensive valuation: SRAD is more expensive than 61.07% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, SRAD is valued quite expensively.
Industry RankSector Rank
PE 63.38
Fwd PE 57.86
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SRAD is valued a bit more expensive than 61.07% of the companies in the same industry.
SRAD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 54.27
EV/EBITDA 18.22
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SRAD may justify a higher PE ratio.
SRAD's earnings are expected to grow with 80.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)2.9
EPS Next 2Y106.68%
EPS Next 3Y80.58%

More info and screens

0

5. Dividend

5.1 Amount

SRAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (8/27/2025, 11:19:07 AM)

31.69

-0.1 (-0.31%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)N/A N/A
Inst Owners78.35%
Inst Owner Change5.44%
Ins Owners1.34%
Ins Owner ChangeN/A
Market Cap9.47B
Analysts81.6
Price Target32.55 (2.71%)
Short Float %2.85%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)277.53%
Min EPS beat(2)141.26%
Max EPS beat(2)413.81%
EPS beat(4)3
Avg EPS beat(4)183.37%
Min EPS beat(4)-100%
Max EPS beat(4)413.81%
EPS beat(8)4
Avg EPS beat(8)77.5%
EPS beat(12)5
Avg EPS beat(12)8.66%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)-0.42%
Revenue beat(4)2
Avg Revenue beat(4)1.39%
Min Revenue beat(4)-1.31%
Max Revenue beat(4)4.89%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)6
Avg Revenue beat(12)0.46%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)7.34%
PT rev (3m)19.33%
EPS NQ rev (1m)-7.16%
EPS NQ rev (3m)6.39%
EPS NY rev (1m)34.13%
EPS NY rev (3m)43.4%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 63.38
Fwd PE 57.86
P/S 6.82
P/FCF 54.27
P/OCF 20.32
P/B 8.54
P/tB N/A
EV/EBITDA 18.22
EPS(TTM)0.5
EY1.58%
EPS(NY)0.55
Fwd EY1.73%
FCF(TTM)0.58
FCFY1.84%
OCF(TTM)1.56
OCFY4.92%
SpS4.64
BVpS3.71
TBVpS-3.11
PEG (NY)0.22
PEG (5Y)2.9
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 11.52%
ROCE 6.34%
ROIC 4.66%
ROICexc 5.53%
ROICexgc N/A
OM 10.53%
PM (TTM) 9.2%
GM 73.35%
FCFM 12.57%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
ROICexc(3y)4.06%
ROICexc(5y)5.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.52%
ROCE(5y)4.82%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.36%
ROICexc growth 5Y-3.96%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.1
Cap/Depr 81.27%
Cap/Sales 21%
Interest Coverage 1.54
Cash Conversion 92.3%
Profit Quality 136.62%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 4.34
F-Score6
WACC5.58%
ROIC/WACC0.83
Cap/Depr(3y)86.86%
Cap/Depr(5y)86.55%
Cap/Sales(3y)21.89%
Cap/Sales(5y)22.44%
Profit Quality(3y)195.32%
Profit Quality(5y)194.81%
High Growth Momentum
Growth
EPS 1Y (TTM)230.77%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%3306.25%
EPS Next Y282.53%
EPS Next 2Y106.68%
EPS Next 3Y80.58%
EPS Next 5Y66.45%
Revenue 1Y (TTM)19.38%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%14.14%
Revenue Next Year17.13%
Revenue Next 2Y17.03%
Revenue Next 3Y16.3%
Revenue Next 5Y14.6%
EBIT growth 1Y25.23%
EBIT growth 3Y36.08%
EBIT growth 5Y22.83%
EBIT Next Year117.8%
EBIT Next 3Y53.12%
EBIT Next 5Y38.81%
FCF growth 1Y476.02%
FCF growth 3Y347.38%
FCF growth 5Y21.32%
OCF growth 1Y86.99%
OCF growth 3Y38.73%
OCF growth 5Y19.31%